Last reviewed · How we verify
High Dose Corticosteroids
High Dose Corticosteroids is a Small molecule drug developed by Rutgers, The State University of New Jersey. It is currently FDA-approved. Also known as: prednisone, methylprednisolone, Solumedrol.
At a glance
| Generic name | High Dose Corticosteroids |
|---|---|
| Also known as | prednisone, methylprednisolone, Solumedrol |
| Sponsor | Rutgers, The State University of New Jersey |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance (PHASE4)
- A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) (PHASE1, PHASE2)
- A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression (PHASE2)
- Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids (PHASE1, PHASE2)
- MAGIC Ruxolitinib for aGVHD (PHASE2)
- Steroid Sparing in Immune Related Hepatitis (irH) (NA)
- Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment (PHASE3)
- Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- High Dose Corticosteroids CI brief — competitive landscape report
- High Dose Corticosteroids updates RSS · CI watch RSS
- Rutgers, The State University of New Jersey portfolio CI
Frequently asked questions about High Dose Corticosteroids
What is High Dose Corticosteroids?
High Dose Corticosteroids is a Small molecule drug developed by Rutgers, The State University of New Jersey.
Who makes High Dose Corticosteroids?
High Dose Corticosteroids is developed and marketed by Rutgers, The State University of New Jersey (see full Rutgers, The State University of New Jersey pipeline at /company/rutgers-the-state-university-of-new-jersey).
Is High Dose Corticosteroids also known as anything else?
High Dose Corticosteroids is also known as prednisone, methylprednisolone, Solumedrol.
What development phase is High Dose Corticosteroids in?
High Dose Corticosteroids is FDA-approved (marketed).
Related
- Manufacturer: Rutgers, The State University of New Jersey — full pipeline
- Also known as: prednisone, methylprednisolone, Solumedrol
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing